BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:40:00 PM | Browse: 375 | Download: 373
Publication Name World Journal of Gastroenterology
Manuscript ID 5496
Country/Territory China
Received
2013-09-11 09:12
Peer-Review Started
2013-09-13 15:28
To Make the First Decision
2013-10-14 21:20
Return for Revision
2013-10-15 19:55
Revised
2013-10-17 12:27
Second Decision
2013-11-01 17:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-03 11:56
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-11-10 13:18
Typeset the Manuscript
2013-11-24 12:28
Publish the Manuscript Online
2013-12-11 16:13
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Autobiography
Article Title "Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
Manuscript Source Invited Manuscript
All Author List Jian-Yong Lei, Wen-Tao Wang and Lu-Nan Yan
Funding Agency and Grant Number
Corresponding author Wen-Tao Wang, MD, PhD, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China. zzphuaxiyiyuanno1@163.com
Keywords Metroticket; Model; Survival; Hepatocellular carcinoma; Liver transplantation
Core Tip The aim of our study was to validate the "Metroticket" predictor using a large cohort of liver transplantation (LT) patients with hepatocellular carcinoma (HCC). The predicted survival rates for all 230 cases, as calculated by the Metroticket model, were 64.7% and 56.2% at 3 and 5 years, respectively, and the observed survival rates for these patients were 71.3% and 62.2%, respectively. For the 23 cases with macrovascular invasion, the predicted 5-year survival rate was 43.5%, whereas the observed 5-year survival rate was only 8.7%. The Metroticket model can be used to accurately predict survival in HCC-related LT cases with an absence of macrovascular invasion.
Publish Date 2013-12-11 16:13
Citation Lei JY, Wang WT, Yan LN. “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China. World J Gastroenterol 2013; 19(44): 8093-8098
Url http://www.wjgnet.com/1007-9327/full/v19/i44/8093.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i44.8093
Full Article (PDF) WJG-19-8093.pdf
Manuscript File 5496-Review.doc
Answering Reviewers 5496-Answering reviewers.pdf
Copyright License Agreement 5496-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5496-Language certificate.pdf
Peer-review Report 5496-Peer reviews.pdf
Scientific Editor Work List 5496-Scientific editor work list.doc